Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001144204-15-068109

President, CEO & Director acquired 150,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

OAKES FRANK R. · President, CEO & Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-11-24 Option exercise : show line 1 in the form −150,000 $2.50 $375,000 193,965 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-11-24 Option exercise : show line 2 in the form Call Option (Obligation to Sell) −150,000 0 D
Loading xslF345X03/v425620_4.xml…